ID   FDFT_HUMAN              Reviewed;         417 AA.
AC   P37268; B3KQ95; B4DJE5; B4DT56; B7Z1J3; Q96GT0;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1994, sequence version 1.
DT   15-MAR-2017, entry version 181.
DE   RecName: Full=Squalene synthase;
DE            Short=SQS;
DE            Short=SS;
DE            EC=2.5.1.21;
DE   AltName: Full=FPP:FPP farnesyltransferase;
DE   AltName: Full=Farnesyl-diphosphate farnesyltransferase;
GN   Name=FDFT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8474436; DOI=10.1128/MCB.13.5.2706;
RA   Robinson G.W., Tsay Y.H., Kienzle B.K., Smith-Monroy C.A.,
RA   Bishop R.W.;
RT   "Conservation between human and fungal squalene synthetases:
RT   similarities in structure, function, and regulation.";
RL   Mol. Cell. Biol. 13:2706-2717(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7685352;
RA   Jiang G., McKenzie T.L., Conrad D.G., Shechter I.;
RT   "Transcriptional regulation by lovastatin and 25-hydroxycholesterol in
RT   HepG2 cells and molecular cloning and expression of the cDNA for the
RT   human hepatic squalene synthase.";
RL   J. Biol. Chem. 268:12818-12824(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=8294001; DOI=10.1016/0378-1119(93)90462-C;
RA   Summers C., Karst F., Charles A.D.;
RT   "Cloning, expression and characterisation of the cDNA encoding human
RT   hepatic squalene synthase, and its relationship to phytoene
RT   synthase.";
RL   Gene 136:185-192(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=7864626; DOI=10.1006/abbi.1995.1095;
RA   Soltis D.A., McMahon G., Caplan S.L., Dudas D.A., Chamberlin H.A.,
RA   Vattay A., Dottavio D., Rucker M.L., Engstrom R.G.,
RA   Cornell-Kennon S.A.;
RT   "Expression, purification, and characterization of the human squalene
RT   synthase: use of yeast and baculoviral systems.";
RL   Arch. Biochem. Biophys. 316:713-723(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3; 4 AND 5).
RC   TISSUE=Cerebellum, Pericardium, Subthalamic nucleus, and Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S.,
RA   Garber M., Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A.,
RA   Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Allen N.R., Anderson S., Asakawa T., Blechschmidt K., Bloom T.,
RA   Borowsky M.L., Butler J., Cook A., Corum B., DeArellano K.,
RA   DeCaprio D., Dooley K.T., Dorris L. III, Engels R., Gloeckner G.,
RA   Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K., Jaffe D.B.,
RA   Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C.,
RA   O'Leary S.B., O'Neill K., Parker S.C.J., Polley A., Raymond C.K.,
RA   Reichwald K., Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R.,
RA   Smith C.L., Sneddon T.P., Talamas J.A., Tenzin P., Topham K.,
RA   Venkataraman V., Wen G., Yamazaki S., Young S.K., Zeng Q.,
RA   Zimmer A.R., Rosenthal A., Birren B.W., Platzer M., Shimizu N.,
RA   Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   ARG-45.
RC   TISSUE=Lung, Muscle, and Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 39-370.
RX   PubMed=10896663; DOI=10.1074/jbc.M004132200;
RA   Pandit J., Danley D.E., Schulte G.K., Mazzalupo S., Pauly T.A.,
RA   Hayward C.M., Hamanaka E.S., Thompson J.F., Harwood H.J. Jr.;
RT   "Crystal structure of human squalene synthase. A key enzyme in
RT   cholesterol biosynthesis.";
RL   J. Biol. Chem. 275:30610-30617(2000).
RN   [12]
RP   VARIANT ARG-45, AND ASSOCIATION WITH PLASMA CHOLESTEROL LEVELS.
RX   PubMed=18350552; DOI=10.1002/humu.20702;
RA   Do R., Pare G., Montpetit A., Hudson T.J., Gaudet D., Engert J.C.;
RT   "K45R variant of squalene synthase increases total cholesterol levels
RT   in two study samples from a French Canadian population.";
RL   Hum. Mutat. 29:689-694(2008).
CC   -!- CATALYTIC ACTIVITY: 2 farnesyl diphosphate + NAD(P)H = squalene +
CC       2 diphosphate + NAD(P)(+).
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- PATHWAY: Terpene metabolism; lanosterol biosynthesis; lanosterol
CC       from farnesyl diphosphate: step 1/3.
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- INTERACTION:
CC       O43889-2:CREB3; NbExp=3; IntAct=EBI-714550, EBI-625022;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Multi-pass
CC       membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P37268-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P37268-2; Sequence=VSP_056283;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=P37268-3; Sequence=VSP_056282;
CC         Note=No experimental confirmation available.;
CC       Name=4;
CC         IsoId=P37268-4; Sequence=VSP_056517;
CC         Note=No experimental confirmation available.;
CC       Name=5;
CC         IsoId=P37268-5; Sequence=VSP_056518;
CC         Note=No experimental confirmation available.;
CC   -!- SIMILARITY: Belongs to the phytoene/squalene synthase family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L06070; AAA60582.1; -; mRNA.
DR   EMBL; L06105; AAA36645.1; -; mRNA.
DR   EMBL; X69141; CAA48896.1; -; mRNA.
DR   EMBL; S76822; AAB33404.1; -; mRNA.
DR   EMBL; AK057726; BAG51957.1; -; mRNA.
DR   EMBL; AK293545; BAH11529.1; -; mRNA.
DR   EMBL; AK296043; BAG58807.1; -; mRNA.
DR   EMBL; AK300059; BAG61868.1; -; mRNA.
DR   EMBL; AK315993; BAH14364.1; -; mRNA.
DR   EMBL; AK316351; BAH14722.1; -; mRNA.
DR   EMBL; AK316531; BAH14902.1; -; mRNA.
DR   EMBL; AK316534; BAH14905.1; -; mRNA.
DR   EMBL; AC069185; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC003573; AAH03573.1; -; mRNA.
DR   EMBL; BC009251; AAH09251.1; -; mRNA.
DR   EMBL; BC029641; AAH29641.1; -; mRNA.
DR   CCDS; CCDS5985.1; -. [P37268-1]
DR   CCDS; CCDS75696.1; -. [P37268-2]
DR   CCDS; CCDS75697.1; -. [P37268-3]
DR   PIR; A45998; A45998.
DR   PIR; I38245; I38245.
DR   PIR; I52090; I52090.
DR   RefSeq; NP_001274671.1; NM_001287742.1. [P37268-1]
DR   RefSeq; NP_001274672.1; NM_001287743.1. [P37268-1]
DR   RefSeq; NP_001274673.1; NM_001287744.1. [P37268-2]
DR   RefSeq; NP_001274674.1; NM_001287745.1. [P37268-2]
DR   RefSeq; NP_001274676.1; NM_001287747.1. [P37268-2]
DR   RefSeq; NP_001274677.1; NM_001287748.1. [P37268-2]
DR   RefSeq; NP_001274678.1; NM_001287749.1. [P37268-2]
DR   RefSeq; NP_001274679.1; NM_001287750.1.
DR   RefSeq; NP_001274680.1; NM_001287751.1. [P37268-3]
DR   RefSeq; NP_001274685.1; NM_001287756.1.
DR   RefSeq; NP_004453.3; NM_004462.4. [P37268-1]
DR   RefSeq; XP_016868706.1; XM_017013217.1. [P37268-2]
DR   UniGene; Hs.593928; -.
DR   PDB; 1EZF; X-ray; 2.15 A; A/B/C=31-370.
DR   PDB; 3ASX; X-ray; 2.00 A; A=31-370.
DR   PDB; 3LEE; X-ray; 3.20 A; A/B/C/D/E/F=31-370.
DR   PDB; 3Q2Z; X-ray; 2.00 A; A=31-370.
DR   PDB; 3Q30; X-ray; 2.00 A; A=31-370.
DR   PDB; 3V66; X-ray; 1.80 A; A=31-370.
DR   PDB; 3VJ8; X-ray; 1.52 A; A=31-370.
DR   PDB; 3VJ9; X-ray; 1.52 A; A=31-370.
DR   PDB; 3VJA; X-ray; 1.76 A; A/B=31-370.
DR   PDB; 3VJB; X-ray; 2.05 A; A/B/C/D/E/F=31-370.
DR   PDB; 3VJC; X-ray; 1.89 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WC9; X-ray; 2.82 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCD; X-ray; 2.75 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCF; X-ray; 2.22 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCH; X-ray; 2.50 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCI; X-ray; 2.30 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCJ; X-ray; 2.20 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCL; X-ray; 2.24 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WCM; X-ray; 2.06 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WEF; X-ray; 2.35 A; A/B/C/D/E/F=31-370.
DR   PDB; 3WEG; X-ray; 1.75 A; A=31-370.
DR   PDB; 3WEH; X-ray; 1.87 A; A=31-370.
DR   PDB; 3WEI; X-ray; 1.79 A; A=31-370.
DR   PDB; 3WEJ; X-ray; 2.00 A; A=31-370.
DR   PDB; 3WEK; X-ray; 1.85 A; A=31-370.
DR   PDB; 3WSA; X-ray; 2.90 A; A/B/C/D/E/F=31-370.
DR   PDBsum; 1EZF; -.
DR   PDBsum; 3ASX; -.
DR   PDBsum; 3LEE; -.
DR   PDBsum; 3Q2Z; -.
DR   PDBsum; 3Q30; -.
DR   PDBsum; 3V66; -.
DR   PDBsum; 3VJ8; -.
DR   PDBsum; 3VJ9; -.
DR   PDBsum; 3VJA; -.
DR   PDBsum; 3VJB; -.
DR   PDBsum; 3VJC; -.
DR   PDBsum; 3WC9; -.
DR   PDBsum; 3WCD; -.
DR   PDBsum; 3WCF; -.
DR   PDBsum; 3WCH; -.
DR   PDBsum; 3WCI; -.
DR   PDBsum; 3WCJ; -.
DR   PDBsum; 3WCL; -.
DR   PDBsum; 3WCM; -.
DR   PDBsum; 3WEF; -.
DR   PDBsum; 3WEG; -.
DR   PDBsum; 3WEH; -.
DR   PDBsum; 3WEI; -.
DR   PDBsum; 3WEJ; -.
DR   PDBsum; 3WEK; -.
DR   PDBsum; 3WSA; -.
DR   ProteinModelPortal; P37268; -.
DR   SMR; P37268; -.
DR   BioGrid; 108516; 29.
DR   IntAct; P37268; 12.
DR   MINT; MINT-1401726; -.
DR   STRING; 9606.ENSP00000220584; -.
DR   BindingDB; P37268; -.
DR   ChEMBL; CHEMBL3338; -.
DR   DrugBank; DB05317; TAK-475.
DR   GuidetoPHARMACOLOGY; 645; -.
DR   SwissLipids; SLP:000000138; -.
DR   iPTMnet; P37268; -.
DR   PhosphoSitePlus; P37268; -.
DR   SwissPalm; P37268; -.
DR   BioMuta; FDFT1; -.
DR   DMDM; 585126; -.
DR   EPD; P37268; -.
DR   PaxDb; P37268; -.
DR   PeptideAtlas; P37268; -.
DR   PRIDE; P37268; -.
DR   DNASU; 2222; -.
DR   Ensembl; ENST00000220584; ENSP00000220584; ENSG00000079459. [P37268-1]
DR   Ensembl; ENST00000443614; ENSP00000390367; ENSG00000079459. [P37268-5]
DR   Ensembl; ENST00000525777; ENSP00000436069; ENSG00000079459. [P37268-3]
DR   Ensembl; ENST00000528643; ENSP00000431649; ENSG00000079459. [P37268-3]
DR   Ensembl; ENST00000528812; ENSP00000431749; ENSG00000079459. [P37268-2]
DR   Ensembl; ENST00000530664; ENSP00000432331; ENSG00000079459. [P37268-2]
DR   Ensembl; ENST00000538689; ENSP00000444248; ENSG00000079459. [P37268-2]
DR   Ensembl; ENST00000615631; ENSP00000481481; ENSG00000079459. [P37268-1]
DR   Ensembl; ENST00000618539; ENSP00000480828; ENSG00000079459. [P37268-1]
DR   Ensembl; ENST00000622850; ENSP00000484122; ENSG00000079459. [P37268-2]
DR   Ensembl; ENST00000623368; ENSP00000485229; ENSG00000079459. [P37268-2]
DR   GeneID; 2222; -.
DR   KEGG; hsa:2222; -.
DR   UCSC; uc003wuh.4; human. [P37268-1]
DR   CTD; 2222; -.
DR   DisGeNET; 2222; -.
DR   GeneCards; FDFT1; -.
DR   H-InvDB; HIX0168873; -.
DR   HGNC; HGNC:3629; FDFT1.
DR   HPA; HPA008874; -.
DR   MalaCards; FDFT1; -.
DR   MIM; 184420; gene.
DR   neXtProt; NX_P37268; -.
DR   OpenTargets; ENSG00000079459; -.
DR   PharmGKB; PA28073; -.
DR   eggNOG; KOG1459; Eukaryota.
DR   eggNOG; COG1562; LUCA.
DR   GeneTree; ENSGT00390000016034; -.
DR   HOGENOM; HOG000186940; -.
DR   HOVERGEN; HBG002370; -.
DR   InParanoid; P37268; -.
DR   KO; K00801; -.
DR   OMA; FHTYLYQ; -.
DR   OrthoDB; EOG091G072P; -.
DR   PhylomeDB; P37268; -.
DR   TreeFam; TF105316; -.
DR   BioCyc; MetaCyc:HS01329-MONOMER; -.
DR   BRENDA; 2.5.1.21; 2681.
DR   Reactome; R-HSA-191273; Cholesterol biosynthesis.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2426168; Activation of gene expression by SREBF (SREBP).
DR   SABIO-RK; P37268; -.
DR   UniPathway; UPA00767; UER00751.
DR   ChiTaRS; FDFT1; human.
DR   EvolutionaryTrace; P37268; -.
DR   GenomeRNAi; 2222; -.
DR   PRO; PR:P37268; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000079459; -.
DR   CleanEx; HS_FDFT1; -.
DR   ExpressionAtlas; P37268; baseline and differential.
DR   Genevisible; P37268; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:HPA.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0004310; F:farnesyl-diphosphate farnesyltransferase activity; IBA:GO_Central.
DR   GO; GO:0016491; F:oxidoreductase activity; IEA:UniProtKB-KW.
DR   GO; GO:0051996; F:squalene synthase activity; IBA:GO_Central.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IBA:GO_Central.
DR   GO; GO:0006696; P:ergosterol biosynthetic process; IEA:InterPro.
DR   GO; GO:0045338; P:farnesyl diphosphate metabolic process; IBA:GO_Central.
DR   GO; GO:0008299; P:isoprenoid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0006694; P:steroid biosynthetic process; TAS:ProtInc.
DR   CDD; cd00683; Trans_IPPS_HH; 1.
DR   Gene3D; 1.10.600.10; -; 1.
DR   InterPro; IPR008949; Isoprenoid_synthase_dom.
DR   InterPro; IPR002060; Squ/phyt_synthse.
DR   InterPro; IPR006449; Squal_synth.
DR   InterPro; IPR019845; Squalene/phytoene_synthase_CS.
DR   InterPro; IPR033904; Trans_IPPS_HH.
DR   Pfam; PF00494; SQS_PSY; 1.
DR   SUPFAM; SSF48576; SSF48576; 1.
DR   TIGRFAMs; TIGR01559; squal_synth; 1.
DR   PROSITE; PS01044; SQUALEN_PHYTOEN_SYN_1; 1.
DR   PROSITE; PS01045; SQUALEN_PHYTOEN_SYN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cholesterol biosynthesis;
KW   Cholesterol metabolism; Complete proteome; Endoplasmic reticulum;
KW   Isoprene biosynthesis; Lipid biosynthesis; Lipid metabolism;
KW   Magnesium; Membrane; Multifunctional enzyme; NADP; Oxidoreductase;
KW   Polymorphism; Reference proteome; Steroid biosynthesis;
KW   Steroid metabolism; Sterol biosynthesis; Sterol metabolism;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN         1    417       Squalene synthase.
FT                                /FTId=PRO_0000067443.
FT   TRANSMEM    284    304       Helical. {ECO:0000255}.
FT   TRANSMEM    384    404       Helical. {ECO:0000255}.
FT   VAR_SEQ       1    111       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056517.
FT   VAR_SEQ       1     85       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056282.
FT   VAR_SEQ       1     64       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056283.
FT   VAR_SEQ     128    170       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056518.
FT   VARIANT      45     45       K -> R (influences plasma cholesterol
FT                                levels; associated with increased total
FT                                cholesterol and non-high-density
FT                                lipoprotein cholesterol;
FT                                dbSNP:rs11549147).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:18350552}.
FT                                /FTId=VAR_011786.
FT   VARIANT     392    392       L -> P (in dbSNP:rs1804473).
FT                                /FTId=VAR_011787.
FT   CONFLICT    353    353       D -> N (in Ref. 4; AAB33404).
FT                                {ECO:0000305}.
FT   CONFLICT    402    402       T -> A (in Ref. 3; CAA48896).
FT                                {ECO:0000305}.
FT   HELIX        38     51       {ECO:0000244|PDB:3VJ8}.
FT   HELIX        52     54       {ECO:0000244|PDB:3VJ8}.
FT   HELIX        55     59       {ECO:0000244|PDB:3VJ8}.
FT   HELIX        65     84       {ECO:0000244|PDB:3VJ8}.
FT   HELIX        90    103       {ECO:0000244|PDB:3VJ8}.
FT   TURN        117    119       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       120    123       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       125    134       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       137    156       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       157    159       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       165    175       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       177    189       {ECO:0000244|PDB:3VJ8}.
FT   STRAND      191    193       {ECO:0000244|PDB:3WEK}.
FT   HELIX       195    199       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       201    218       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       220    225       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       233    236       {ECO:0000244|PDB:3VJ8}.
FT   TURN        237    239       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       243    247       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       249    251       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       252    267       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       270    278       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       283    303       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       307    310       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       318    327       {ECO:0000244|PDB:3VJ8}.
FT   STRAND      328    330       {ECO:0000244|PDB:3VJC}.
FT   HELIX       331    346       {ECO:0000244|PDB:3VJ8}.
FT   HELIX       356    368       {ECO:0000244|PDB:3VJ8}.
SQ   SEQUENCE   417 AA;  48115 MW;  D36CBC8382F827EC CRC64;
     MEFVKCLGHP EEFYNLVRFR IGGKRKVMPK MDQDSLSSSL KTCYKYLNQT SRSFAAVIQA
     LDGEMRNAVC IFYLVLRALD TLEDDMTISV EKKVPLLHNF HSFLYQPDWR FMESKEKDRQ
     VLEDFPTISL EFRNLAEKYQ TVIADICRRM GIGMAEFLDK HVTSEQEWDK YCHYVAGLVG
     IGLSRLFSAS EFEDPLVGED TERANSMGLF LQKTNIIRDY LEDQQGGREF WPQEVWSRYV
     KKLGDFAKPE NIDLAVQCLN ELITNALHHI PDVITYLSRL RNQSVFNFCA IPQVMAIATL
     AACYNNQQVF KGAVKIRKGQ AVTLMMDATN MPAVKAIIYQ YMEEIYHRIP DSDPSSSKTR
     QIISTIRTQN LPNCQLISRS HYSPIYLSFV MLLAALSWQY LTTLSQVTED YVQTGEH
//
